FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3075293132> ?p ?o ?g. }

• W3075293132 abstract "Neuronal accumulation of misfolded microtubule-associated protein tau is a hallmark of neuropathology in Alzheimer's disease, frontotemporal dementia, and other tauopathies, and has been a therapeutic target. Microglia can spread tau pathology by secreting tau-containing exosomes, although the specific molecular target is yet to be identified for the therapeutic intervention. P2X purinoceptor 7 (P2RX7) is an ATP-gated cation channel, enriched in microglia and triggers exosome secretion. The purpose of the study is to examine the therapeutic effect of an orally applicable, CNS-penetrant P2RX7 specific inhibitor on the early disease stage of a tauopathy mouse model.Three-months-old P301S tau mice were treated with P2RX7-specific inhibitor GSK1482160 or vehicle for 30 days, followed by behavioral, biochemical and immunohistochemical assessment. GSK1482160 was also tested for exosome secretion from primary cultured murine astrocytes, neurons and microglia in vitro.Oral administration of GSK1482160 significantly reduced accumulation of MC1+ and Alz50+ misfolded tau in hippocampal regions, which was accompanied with reduced accumulation of Tsg101, an exosome marker, in hippocampal neurons. Proximity ligation assay demonstrated complex formation of Alz50+ tau and Tsg101 in hippocampal neurons, which was reduced by GSK1482160. On the other hand, GSK1482160 had no effect on microglial ramification or CD68 expression, which was significantly enhanced in P301S mice, or pro/anti-inflammatory cytokine gene expression. Strikingly, GSK1482160-treated P301S mice show significantly improved working and contextual memory as determined by Y-maze and fear conditioning tests. GSK1482160 also significantly increased accumulation of Tsg101 and CD81 in microglia in vivo, suggesting its suppression of P2RX7-induced exosome secretion from microglia. This effect was confirmed in vitro, as ATP-induced secretion of tau-containing exosome was significantly suppressed by GSK1482160 treatment from primary murine microglia, but not from neurons or astrocytes.The oral administration of P2RX7 inhibition mitigates disease phenotypes in P301S mice, likely by suppressing release of microglial exosomes. P2RX7 could be a novel therapeutic target for the early stage tauopathy development." @default.
• W3075293132 created "2020-08-24" @default.
• W3075293132 creator A5008524903 @default.
• W3075293132 creator A5037301357 @default.
• W3075293132 creator A5050139699 @default.
• W3075293132 creator A5057205558 @default.
• W3075293132 creator A5066840453 @default.
• W3075293132 creator A5080101948 @default.
• W3075293132 creator A5084449096 @default.
• W3075293132 date "2020-08-18" @default.
• W3075293132 modified "2023-10-15" @default.
• W3075293132 title "P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice" @default.
• W3075293132 cites W1511517753 @default.
• W3075293132 cites W1601973441 @default.
• W3075293132 cites W1824528611 @default.
• W3075293132 cites W1963634927 @default.
• W3075293132 cites W1966398396 @default.
• W3075293132 cites W1981706572 @default.
• W3075293132 cites W1982487434 @default.
• W3075293132 cites W1984005657 @default.
• W3075293132 cites W1986175732 @default.
• W3075293132 cites W2024041849 @default.
• W3075293132 cites W2041034105 @default.
• W3075293132 cites W2052742260 @default.
• W3075293132 cites W2054275187 @default.
• W3075293132 cites W2057249855 @default.
• W3075293132 cites W2069219003 @default.
• W3075293132 cites W2070307854 @default.
• W3075293132 cites W2100358971 @default.
• W3075293132 cites W2102795669 @default.
• W3075293132 cites W2103686849 @default.
• W3075293132 cites W2135661040 @default.
• W3075293132 cites W2153177211 @default.
• W3075293132 cites W2161102922 @default.
• W3075293132 cites W2165324329 @default.
• W3075293132 cites W2165725890 @default.
• W3075293132 cites W2175666020 @default.
• W3075293132 cites W2190404250 @default.
• W3075293132 cites W2512797224 @default.
• W3075293132 cites W2555636200 @default.
• W3075293132 cites W2727929522 @default.
• W3075293132 cites W2737555531 @default.
• W3075293132 cites W2770027158 @default.
• W3075293132 cites W2774859152 @default.
• W3075293132 cites W2808809552 @default.
• W3075293132 cites W2885935758 @default.
• W3075293132 cites W2905210080 @default.
• W3075293132 cites W2924831238 @default.
• W3075293132 cites W2952148208 @default.
• W3075293132 cites W2954072698 @default.
• W3075293132 cites W2968451481 @default.
• W3075293132 cites W2996950260 @default.
• W3075293132 cites W3014222043 @default.
• W3075293132 cites W3021184947 @default.
• W3075293132 cites W751975581 @default.
• W3075293132 doi "https://doi.org/10.1186/s13024-020-00396-2" @default.
• W3075293132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7436984" @default.
• W3075293132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32811520" @default.
• W3075293132 hasPublicationYear "2020" @default.
• W3075293132 type Work @default.
• W3075293132 sameAs 3075293132 @default.
• W3075293132 citedByCount "60" @default.
• W3075293132 countsByYear W30752931322020 @default.
• W3075293132 countsByYear W30752931322021 @default.
• W3075293132 countsByYear W30752931322022 @default.
• W3075293132 countsByYear W30752931322023 @default.
• W3075293132 crossrefType "journal-article" @default.
• W3075293132 hasAuthorship W3075293132A5008524903 @default.
• W3075293132 hasAuthorship W3075293132A5037301357 @default.
• W3075293132 hasAuthorship W3075293132A5050139699 @default.
• W3075293132 hasAuthorship W3075293132A5057205558 @default.
• W3075293132 hasAuthorship W3075293132A5066840453 @default.
• W3075293132 hasAuthorship W3075293132A5080101948 @default.
• W3075293132 hasAuthorship W3075293132A5084449096 @default.
• W3075293132 hasBestOaLocation W30752931321 @default.
• W3075293132 hasConcept C102230213 @default.
• W3075293132 hasConcept C104317684 @default.
• W3075293132 hasConcept C141035611 @default.
• W3075293132 hasConcept C142724271 @default.
• W3075293132 hasConcept C145059251 @default.
• W3075293132 hasConcept C148762608 @default.
• W3075293132 hasConcept C169760540 @default.
• W3075293132 hasConcept C203014093 @default.
• W3075293132 hasConcept C20518536 @default.
• W3075293132 hasConcept C2776914184 @default.
• W3075293132 hasConcept C2776925932 @default.
• W3075293132 hasConcept C2777739294 @default.
• W3075293132 hasConcept C2778670691 @default.
• W3075293132 hasConcept C2779134260 @default.
• W3075293132 hasConcept C2779830541 @default.
• W3075293132 hasConcept C2781261824 @default.
• W3075293132 hasConcept C502032728 @default.
• W3075293132 hasConcept C55493867 @default.
• W3075293132 hasConcept C71924100 @default.
• W3075293132 hasConcept C86803240 @default.
• W3075293132 hasConcept C95444343 @default.
• W3075293132 hasConceptScore W3075293132C102230213 @default.
• W3075293132 hasConceptScore W3075293132C104317684 @default.
• W3075293132 hasConceptScore W3075293132C141035611 @default.
• W3075293132 hasConceptScore W3075293132C142724271 @default.

• next